Publication

Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV:Data from the Veterans Aging Cohort Study

Downloadable Content

Persistent URL
Last modified
  • 05/14/2025
Type of Material
Authors
    Brittanny M. Polanka, Indiana UniversitySuman Kundu, Emory UniversityKaku A. So-Armah, Boston UniversityMatthew S. Freiberg, Vanderbilt UniversitySamir K. Gupta, Indiana UniversityRoger J. Bedimo, VA North Texas Healthcare SystemMatthew J. Budoff, Los Angeles Biomedical Research InstituteAdeel A. Butt, Weill Cornell Medical CollegeChung-Chou H. Chang, University of PittsburghStephen S. Gottlieb, University of MarylandVincent Marconi, Emory UniversityJulie A. Womack, Yale UniversityJesse C. Stewart, Indiana University
Language
  • English
Date
  • 2019-05-01
Publisher
  • Lippincott, Williams & Wilkins
Publication Version
Copyright Statement
  • © 2019 Wolters Kluwer Health, Inc.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 81
Issue
  • 1
Start Page
  • 110
End Page
  • 117
Grant/Funding Information
  • The Veterans Aging Cohort Study was funded by grant U10AA13566 from the National Institute on Alcohol Abuse and Alcoholism and Veterans Health Administration Public Health Strategic Health Core Group.
  • This analysis was funded in part by grant R01HL126557 from the National Institutes of Health.
Supplemental Material (URL)
Abstract
  • Background: Insomnia is associated with increased cardiovascular disease (CVD) risk in the general population and is highly prevalent in people with HIV. The CVD risk conferred by insomnia in the HIV population is unknown. Methods: Using the Veterans Aging Cohort Study-Survey Cohort, insomnia symptoms were measured and dummy coded with the item, “Difficulty falling or staying asleep?” (5-point scale from no difficulty to bothers a lot). Incident CVD event ICD-9 codes (acute myocardial infarction, stroke, or coronary artery revascularization) were identified with VA and Medicare administrative data and VA fee-for-service data. Those with baseline CVD were excluded. Results: HIV-infected (N=3,108) veterans had a median follow-up time of 10.8 years, during which 267 CVD events occurred. Compared to HIV-infected veterans with no difficulty falling or staying asleep, HIV-infected veterans bothered a lot by insomnia symptoms had an increased risk of incident CVD after adjusting for demographics (HR=1.64, 95%CI=1.16–2.31, p=.005), CVD risk factors (HR=1.62, 95%CI=1.14–2.30, p=.007), additional potential confounders (hepatitis C infection, renal disease, anemia, alcohol use, cocaine use; HR=1.70, 95%CI=1.19–2.43, p=.003), and HIV-specific factors (HIV-1 RNA, CD4+ T-cell count, ART; HR=1.66, 95%CI=1.16–2.37, p=.005). Additional adjustment for non-benzodiazepine sleep medication (HR=1.62, 95%CI=1.13–2.32, p=.009) did not attenuate the association; however, it fell short of significance at p < .01 after adjustment for depressive symptoms (HR=1.51, 95%CI=0.98–2.32, p=.060) or antidepressant medication (HR=1.51, 95%CI=1.04–2.19, p=.031). Conclusion: Highly bothersome insomnia symptoms were significantly associated with incident CVD in HIV-infected veterans, suggesting that insomnia may be a novel, modifiable risk factor for CVD in HIV.
Author Notes
  • Correspondence: Jesse C. Stewart, PhD, Department of Psychology, Indiana University-Purdue University Indianapolis (IUPUI), 402 N. Blackford St., LD 100E, Indianapolis, IN 46202. Telephone: (317) 274-6761. Fax: (317) 274-6756. jstew@iupui.edu
Keywords
Research Categories
  • Psychology, Cognitive
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Immunology
  • Health Sciences, Health Care Management

Tools

Relations

In Collection:

Items